D-1625-2020 Class III Terminated
FDA drug recall D-1625-2020 was initiated by Arbor Pharmaceuticals Inc. on Sep 16, 2020 and is designated Class III. Reason for recall: Subpotent Drug The recall status is terminated (terminated Feb 22, 2022). Affected quantity: 1846 cartons.
Recall details
- Product Type
- Drugs
- Report Date
- Oct 7, 2020
- Initiation Date
- Sep 16, 2020
- Termination Date
- Feb 22, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1846 cartons
Product description
Nymalize (nimodipine) oral solution, 60 mg/20 mL, 12 Unit-Dose Cups and 12 Oral Syringes, 2 inner cartons per outer shipping carton, Rx Only, Distributed by arbor Atlanta, GA, NDC 24338-200-12
Reason for recall
Subpotent Drug
Distribution pattern
Nationwide within the United States
Code information
Lot #: 356884 Exp. 11/30/2021
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1625-2020
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026